Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women

https://doi.org/10.1016/0002-9343(87)90493-1Get rights and content

Abstract

Fifty elderly (mean age, 83.4 ± 8.8 years) institutionalized women with asymptomatic bacteriuria were randomly assigned either to receive therapy for treatment of all episodes of bacteriuria identified on monthly culture or to receive no therapy unless symptoms developed. Subjects were followed for one year. The therapy group had a mean monthly prevalence of bacteriuria 31 ± 15 percent lower than those in the no-therapy group, but periods free of bacteriuria lasting six months or longer were documented for only five (24 percent) subjects. For residents receiving no therapy, 71 percent showed persistent infection with the same organism(s). Antimicrobial therapy was associated with an increased incidence of reinfection (1.67 versus 0.87 per patient-year) and adverse antimicrobial drug effects (0.51 versus 0.046 per patient-year) as well as isolation of increasingly resistant organisms in recurrent infection when compared with no therapy. No differences in genitourinary morbidity or mortality were observed between the groups. Thus, despite a lowered prevalence of bacteriuria, no short-term benefits were identified and some harmful effects were observed with treatment of asymptomatic bacteriuria. These data support current recommendations of no therapy for asymptomatic bacteriuria in this population.

References (0)

Cited by (277)

  • Correlation of Pyuria and Bacteriuria in Acute Care

    2022, American Journal of Medicine
  • Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

    2020, Revue Neurologique
    Citation Excerpt :

    Very little literature is available concerning the management of ABU (colonization) exclusively in MS. So, evaluation of the literature was extended to studies concerning the general population (elderly patients) as well as populations of patients with neurologic bladder in the case of spinal cord injury. The treatment of ABU of elderly institutionalized patients did not modify the morbidity-mortality but increased the emergence of multidrug-resistant bacteria [115,116]. ABU in cases of neurologic bladder was studied mainly with respect to self-intermittent catheterization of patients with spinal cord injury and the prevalence was high, reaching sometimes 89% [103].

View all citing articles on Scopus

This work was presented in part at the 21st Interscience Congress on Chemotherapy, Washington 1984; the 14th International Congress of Chemotherapy, Kyoto 1985; and the annual meeting of the Royal College of Physicians and Surgeons of Canada, Vancouver 1985. This study was funded in part by a grant from the Foothills Hospital Research and Development Fund and in part by an Establishment Grant from the Alberta Heritage Foundation for Medical Research.

*

Current address and address for reprint requests: Infection Control Unit, MS-675D, Health Sciences Centre, 820 Sherbrooke Street, Winnipeg, Manitoba, R3A 1R9 Canada.

View full text